Sandoz Group AG

Swiss Stock Exchange SDZ.SW

Sandoz Group AG Free Cash Flow for the year ending December 31, 2023: USD -242.64 M

Sandoz Group AG Free Cash Flow is USD -242.64 M for the year ending December 31, 2023, a -131.92% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • Sandoz Group AG Free Cash Flow for the year ending December 31, 2022 was USD 760.23 M, a -11.16% change year over year.
  • Sandoz Group AG Free Cash Flow for the year ending December 31, 2021 was USD 855.75 M, a 18.71% change year over year.
  • Sandoz Group AG Free Cash Flow for the year ending December 31, 2020 was USD 720.86 M.
Key data
Date Free Cash Flow Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities
Market news
Loading...
Swiss Stock Exchange: SDZ.SW

Sandoz Group AG

CEO Mr. Richard Saynor
IPO Date Oct. 3, 2023
Location Switzerland
Headquarters Suurstoffi 14
Employees 22,633
Sector Health Care
Industries
Description

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.

StockViz Staff

January 15, 2025

Any question? Send us an email